These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 28605348)

  • 1. Essential Mechanisms of Differential Activation of Eosinophils by IL-3 Compared to GM-CSF and IL-5.
    Esnault S; Kelly EA
    Crit Rev Immunol; 2016; 36(5):429-444. PubMed ID: 28605348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-3 Maintains Activation of the p90S6K/RPS6 Pathway and Increases Translation in Human Eosinophils.
    Esnault S; Kelly EA; Shen ZJ; Johansson MW; Malter JS; Jarjour NN
    J Immunol; 2015 Sep; 195(6):2529-39. PubMed ID: 26276876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Eosinophils Express a Distinct Gene Expression Program in Response to IL-3 Compared with Common β-Chain Cytokines IL-5 and GM-CSF.
    Nelson RK; Brickner H; Panwar B; Ramírez-Suástegui C; Herrera-de la Mata S; Liu N; Diaz D; Alexander LEC; Ay F; Vijayanand P; Seumois G; Akuthota P
    J Immunol; 2019 Jul; 203(2):329-337. PubMed ID: 31175163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience.
    Varricchi G; Bagnasco D; Ferrando M; Puggioni F; Passalacqua G; Canonica GW
    Ther Adv Respir Dis; 2017 Jan; 11(1):40-45. PubMed ID: 27856823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New approaches in the treatment of asthma.
    Ramshaw HS; Woodcock JM; Bagley CJ; McClure BJ; Hercus TR; Lopez AF
    Immunol Cell Biol; 2001 Apr; 79(2):154-9. PubMed ID: 11264710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of blood mononuclear cells of atopic children with the relevant allergen induces the release of eosinophil chemotaxins such as IL-3, IL-5, and GM-CSF.
    Lantero S; Sacco O; Scala C; Rossi GA
    J Asthma; 1997; 34(2):141-52. PubMed ID: 9088301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of eosinophil β chain-signaling cytokines receptors, outer-membrane integrins, and type 2 inflammation biomarkers in severe non-allergic eosinophilic asthma.
    Kalinauskaite-Zukauske V; Januskevicius A; Janulaityte I; Miliauskas S; Malakauskas K
    BMC Pulm Med; 2019 Aug; 19(1):158. PubMed ID: 31438916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of human eosinophil and neutrophil functions by haematopoietic growth factors: comparisons of IL-1, IL-3, IL-5 and GM-CSF.
    Fabian I; Kletter Y; Mor S; Geller-Bernstein C; Ben-Yaakov M; Volovitz B; Golde DW
    Br J Haematol; 1992 Feb; 80(2):137-43. PubMed ID: 1550768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.
    Heinisch IV; Bizer C; Volgger W; Simon HU
    J Allergy Clin Immunol; 2001 Jul; 108(1):21-8. PubMed ID: 11447378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement and Possible Role of Eosinophils in Asthma Exacerbation.
    Nakagome K; Nagata M
    Front Immunol; 2018; 9():2220. PubMed ID: 30323811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed eosinophil apoptosis in asthma.
    Kankaanranta H; Lindsay MA; Giembycz MA; Zhang X; Moilanen E; Barnes PJ
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):77-83. PubMed ID: 10887309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral regulation of eosinophilopoiesis in vitro: analysis of the targets of interleukin-3, granulocyte/macrophage colony-stimulating factor (GM-CSF), and interleukin-5.
    Sonoda Y; Arai N; Ogawa M
    Leukemia; 1989 Jan; 3(1):14-8. PubMed ID: 2642572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-3-induced up-regulation of CR3 expression on human eosinophils is inhibited by dexamethasone.
    Hartnell A; Kay AB; Wardlaw AJ
    Immunology; 1992 Dec; 77(4):488-93. PubMed ID: 1493920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of transendothelial migration on eosinophil function.
    Yamamoto H; Sedgwick JB; Vrtis RF; Busse WW
    Am J Respir Cell Mol Biol; 2000 Sep; 23(3):379-88. PubMed ID: 10970830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: Asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis.
    Nagase H; Ueki S; Fujieda S
    Allergol Int; 2020 Apr; 69(2):178-186. PubMed ID: 32139163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophils express functional IL-13 in eosinophilic inflammatory diseases.
    Schmid-Grendelmeier P; Altznauer F; Fischer B; Bizer C; Straumann A; Menz G; Blaser K; Wüthrich B; Simon HU
    J Immunol; 2002 Jul; 169(2):1021-7. PubMed ID: 12097410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma.
    Wallaert B; Desreumaux P; Copin MC; Tillie I; Benard A; Colombel JF; Gosselin B; Tonnel AB; Janin A
    J Exp Med; 1995 Dec; 182(6):1897-904. PubMed ID: 7500035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors.
    Panousis C; Dhagat U; Edwards KM; Rayzman V; Hardy MP; Braley H; Gauvreau GM; Hercus TR; Smith S; Sehmi R; McMillan L; Dottore M; McClure BJ; Fabri LJ; Vairo G; Lopez AF; Parker MW; Nash AD; Wilson NJ; Wilson MJ; Owczarek CM
    MAbs; 2016; 8(3):436-53. PubMed ID: 26651396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential contribution of IL-7 to allergen-induced eosinophilic airway inflammation in asthma.
    Kelly EA; Koziol-White CJ; Clay KJ; Liu LY; Bates ME; Bertics PJ; Jarjour NN
    J Immunol; 2009 Feb; 182(3):1404-10. PubMed ID: 19155487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome.
    Schrezenmeier H; Thomé SD; Tewald F; Fleischer B; Raghavachar A
    Exp Hematol; 1993 Feb; 21(2):358-65. PubMed ID: 8425573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.